HFS
AXSM icon

Hughes Financial Services’s Axsome Therapeutics AXSM Stock Holding History

Hughes Financial Services’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.18K Buy
7
+6
+600% +$1.04K ﹤0.01% 723
2025
Q4 		$183 Buy
+1
New +$140 ﹤0.01% 1001

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hughes Financial Services's AXSM Position: Q1 2026 in Review

Hughes Financial Services increased its Axsome Therapeutics (AXSM) stake by 600% in Q1 2026, buying an estimated $1.04K and bringing the position to 7 shares worth $1.18K. The position accounts for ﹤0.01% of the portfolio, ranked #723.

Hughes Financial Services first reported a position in AXSM in Q4 2025 and has held it in 2 quarters since. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Hughes Financial Services held 7 shares of Axsome Therapeutics worth $1.18K as of Q1 2026.
  • Hughes Financial Services bought 6 Axsome Therapeutics shares in Q1 2026, an estimated $1.04K.
  • Axsome Therapeutics made up ﹤0.01% of Hughes Financial Services's portfolio in Q1 2026, its #723 holding.
  • Hughes Financial Services first reported a position in Axsome Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Hughes Financial Services's 13F filing for Q1 2026, filed 29 Apr 2026.